IRIDEX Corp at ROTH Conference Transcript
Okay, we are going to move on to our next presentation from IRIDEX Corporation, ticker IRIX. An approximately $65 million market cap medical device company focused on ocular indications.
Presenting for the Company is George Marcellino, Vice President of Medical Affairs. Take it away, George, and thank you for coming.
Thank you very much. Very good; thank you very much for coming today. Will Moore, our CEO, was unable to attend and so he asked me to stand in for him. It's certainly a pleasure to be here today addressing you.
And I thought I might just start off with a brief bio because it's doubtful that any of you who know I am. So I have -- I will keep it germane to this industry, but I've been in the medical device industry for 40 years. And 30 of that has been in the application of lasers for both medicine and surgery and most of that has been for ophthalmology.
So I spent 15 years at Coherent, and highlights of that time were the introduction of selective
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |